Page History
Completed by: | Steve Kopko |
Date Completed: | 28 Mar |
Name and Version of Project: | Short Form 36 Health Survey Acute, US Version 2.0 (SF36 V2.0 ACUTE); Supplement version V1.0 |
BEFORE POSTING FOR PUBLIC REVIEW
- All internal review comments have been resolved and updated in JIRA.
- Supplement has been through copy-editing. This is no longer necessay for Public Review.
- Not an FDA priority
- If the supplement is an FDA priority, it has gone through FDA review and additional copy-editing if there were extensive changes.
The FDA priority list has been checked to see if the supplement is marked "yes".- The FDA disclaimer is in the supplement if they reviewed it and not in the supplement if it's not an FDA priority.
- Notify the SDS QRS Subteam that the supplements are ready for public review.
- Announcement has been prepared.
- Project Manager/Team Lead notified Ann White (Communications) at least 5 days before planned public review posting so she can review the announcement and post to the CDISC website.
...
Overview
Content Tools